Recent advances in stem cell research have made it possible to generate specific cell types and organs outside of the body, enabling groundbreaking new treatments for a variety of conditions.  Pancreatic cells generated from stem cells are being infused into patients with diabetes, and mini-brains are being built to study neurological disorders.

Join Swissnex and the University of Basel for a hybrid panel discussion on how these and other breakthroughs are providing new opportunities to study development and treat disease. Professor Alex Schier, Director of University of Basel’s Biozentrum, a globally leading life sciences institute, will moderate the discussion. He will be joined by leading voices in the field on both sides of the Atlantic: Doug Melton of Harvard University and Vertex Pharmaceuticals, Kara McKinley of Harvard, Barbara Treutlein of ETH Zurich’s Basel-based Department of Biosystems Science and Engineering, Ivan Martin of the University of Basel, and Hans Clevers of Roche and Hubrecht University. Together, they will explore how cell and organ engineering is catalyzing a new era of life sciences innovation.